We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
-11.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.06B
AUM Growth
+$226M
Cap. Flow
+$653M
Cap. Flow %
21.38%
Top 10 Hldgs %
83.2%
Holding
374
New
73
Increased
133
Reduced
109
Closed
49

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$334M
2
JD icon
JD.com
JD
+$84.6M
3
BIDU icon
Baidu
BIDU
+$84.3M
4
NTES icon
NetEase
NTES
+$50.9M
5
PDD icon
Pinduoduo
PDD
+$50.6M

Top Sells

Rank Stock Value
1
NIO icon
NIO
NIO
+$10.7M
2
KC
Kingsoft Cloud Holdings
KC
+$9.2M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.55M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$7.48M
5
MOMO
Hello Group
MOMO
+$6.64M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 63.45%
2 Communication Services 21.89%
3 Technology 6.77%
4 Healthcare 2.16%
5 Financials 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRT icon
176
Copart
CPRT
$30.6B
$328K 0.01%
10,464
-208
-2% -$6.61K
NEE icon
177
NextEra Energy
NEE
$170B
$324K 0.01%
3,828
-501
-12% -$40.2K
CDNA icon
178
CareDx
CDNA
$2.58B
$322K 0.01%
+8,715
New +$340K
ARCT icon
179
Arcturus Therapeutics
ARCT
$439M
$321K 0.01%
+11,910
New +$304K
LIN icon
180
Linde
LIN
$225B
$319K 0.01%
1,000
-135
-12% -$41.7K
NTLA icon
181
Intellia Therapeutics
NTLA
$1.82B
$318K 0.01%
+4,377
New +$371K
ZS icon
182
Zscaler
ZS
$29.8B
$318K 0.01%
1,316
– –
BBIO icon
183
BridgeBio Pharma
BBIO
$15B
$317K 0.01%
+31,264
New +$321K
VIR icon
184
Vir Biotechnology
VIR
$1.84B
$316K 0.01%
+12,283
New +$364K
APLS
185
DELISTED
Apellis Pharmaceuticals
APLS
$315K 0.01%
+6,196
New +$274K
VCYT icon
186
Veracyte
VCYT
$3.51B
$311K 0.01%
+11,276
New +$323K
FATE icon
187
Fate Therapeutics
FATE
$292M
$310K 0.01%
7,996
+4,468
+127% +$173K
IONS icon
188
Ionis Pharmaceuticals
IONS
$10.1B
$309K 0.01%
+8,334
New +$273K
HALO icon
189
Halozyme
HALO
$11.9B
$308K 0.01%
7,726
+2,699
+54% +$96.1K
UPS icon
190
United Parcel Service
UPS
$89.6B
$305K 0.01%
1,423
-184
-11% -$39.1K
TWST icon
191
Twist Bioscience
TWST
$8.94B
$303K 0.01%
+6,126
New +$340K
EBS icon
192
Emergent Biosolutions
EBS
$304M
$302K 0.01%
+7,354
New +$324K
BPMC
193
DELISTED
Blueprint Medicines
BPMC
$300K 0.01%
+4,698
New +$337K
KEYS icon
194
Keysight
KEYS
$54.2B
$300K 0.01%
1,901
+111
+6% +$18.5K
EXAS
195
DELISTED
Exact Sciences
EXAS
$299K 0.01%
+4,275
New +$312K
INO icon
196
Inovio Pharmaceuticals
INO
$132M
$299K 0.01%
6,942
+4,561
+192% +$205K
KPTI icon
197
Karyopharm Therapeutics
KPTI
$42.6M
$299K 0.01%
2,705
+1,879
+227% +$234K
DVAX
198
DELISTED
Dynavax Technologies
DVAX
$298K 0.01%
27,513
+14,567
+113% +$177K
RARE icon
199
Ultragenyx Pharmaceutical
RARE
$2.52B
$298K 0.01%
+4,101
New +$285K
ARWR icon
200
Arrowhead Research
ARWR
$12.1B
$295K 0.01%
+6,421
New +$318K
6 7
8
9 10

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2022 Portfolio in Review

As of Q1 2022, E Fund Management held 374 positions worth $3.06B, up 8% from $2.83B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

E Fund Management deployed $653M of net new capital in Q1 2022, opening 73 new positions and adding to 133 existing holdings. Its largest new stake was Natera: 6,882 shares worth $280K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, up from 61% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was United States Brent Oil Fund, an estimated $6.01M trimmed.

  • E Fund Management's largest Q1 2022 buy was Natera: 6,882 shares worth $280K.
  • E Fund Management added most to Alibaba in Q1 2022, an estimated $334M increase.
  • E Fund Management's biggest Q1 2022 reduction was United States Brent Oil Fund, cutting an estimated $6.01M.
  • E Fund Management fully exited NIO in Q1 2022, selling an estimated $10.7M.
  • E Fund Management's ten largest holdings make up 83% of its $3.06B portfolio in Q1 2022.
  • E Fund Management opened 73 new positions and closed 49 in Q1 2022.
  • E Fund Management's portfolio value rose 8% quarter-over-quarter to $3.06B.

Based on E Fund Management's 13F filing for Q1 2022, filed 12 May 2022.